Clematichinenoside AR ameliorated spontaneous colitis in Il-10−/− mice associated with improving the intestinal barrier function and abnormal immune responses

ConclusionsAR may have therapeutic potential for treating CD in humans.
Source: Life Sciences - Category: Biology Source Type: research